Income Statement Pilulka Lékárny

Stocks

PINK

CZ0009009874

Drug Retailers

End-of-day quote Prague S.E. 17/09/2026			5-day change	1st Jan Change
113.00 ^CZK	+1.80%		-2.59%	-33.53%

06-15	Pilulka Lékárny a.s. Auditor Raises 'Going Concern' Doubt	CI
06-15	Pilulka Lékárny a.s. Reports Earnings Results for the Full Year Ended December 31, 2025	CI

eed0f52cc853d200ae4ea80436fb5._GjuFmhaaSeTsy2foZP9uZjCICrJHrGUwAxyAm3euus.ix-vdTcfG27qwE_bxqG_wMmldHCDbefcsnlKTQTmjYyNWtt7DgIQXvXHGQ

Published financial data: PILULKA LÉKÁRNY

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (CZK)	2022 (CZK)	2023 (CZK)	2024 (CZK)	2025 (CZK)
Revenues	2.38B	2.45B	2.13B	1.3B	876M
Total Revenues	2.38B	2.45B	2.13B	1.3B	876M
Cost of Goods Sold, Total	2.37B	2.45B	1.83B	1.12B	746M
Gross Profit	13.52M	273K	297M	183M	131M
Selling General & Admin Expenses, Total	-	-	364M	229M	181M
Depreciation & Amortization - (IS)	-	-	73.94M	72.91M	28.29M
Amortization of Goodwill and Intangible Assets - (IS)	12.17M	2.36M	-	-	-
Other Operating Expenses	15.4M	45.66M	7.51M	-8.69M	-61.94M
Other Operating Expenses, Total	27.57M	48.01M	446M	293M	147M
Operating Income	-14.05M	-47.74M	-149M	-110M	-16.48M
Interest Expense, Total	-777K	-4.76M	-10.48M	-12.33M	-16.98M
Interest And Investment Income	714K	206K	49K	6K	6K
Net Interest Expenses	-63K	-4.56M	-10.43M	-12.33M	-16.97M
Other Non Operating Income (Expenses)	-10.56M	-11.71M	-16.88M	-12.68M	-6.78M
EBT, Excl. Unusual Items	-24.68M	-64.01M	-176M	-135M	-40.23M
Gain (Loss) On Sale Of Assets	-	-	19K	8.56M	1.72M
EBT, Incl. Unusual Items	-24.68M	-64.01M	-176M	-126M	-38.51M
Income Tax Expense	994K	1.75M	4K	-	107K
Earnings From Continuing Operations	-25.67M	-65.76M	-176M	-126M	-38.62M
Net Income to Company	-25.67M	-65.76M	-176M	-126M	-38.62M
Minority Interest	175K	820K	932K	635K	-251K
Net Income - (IS)	-25.5M	-64.94M	-175M	-126M	-38.87M
Net Income to Common Incl Extra Items	-25.5M	-64.94M	-175M	-126M	-38.87M
Net Income to Common Excl. Extra Items	-25.5M	-64.94M	-175M	-126M	-38.87M
Per Share Items
Net EPS - Basic	-	-25.76	-64.63	-46.46	-14.36
Basic EPS - Continuing Operations	-	-25.76	-64.63	-46.46	-14.36
Basic Weighted Average Shares Outstanding	-	2.52M	2.71M	2.71M	2.71M
Net EPS - Diluted	-	-25.76	-64.63	-46.46	-14.36
Diluted EPS - Continuing Operations	-	-25.76	-64.63	-46.46	-14.36
Diluted Weighted Average Shares Outstanding	-	2.52M	2.71M	2.71M	2.71M
Normalized Basic EPS	-	-15.54	-40.27	-30.92	-9.38
Normalized Diluted EPS	-	-15.54	-40.27	-30.92	-9.38
Supplemental Items
EBITDA	8.26M	-29.89M	-126M	-90.27M	-1.52M
EBITA	-1.03M	-44.56M	-146M	-108M	-14.13M
EBIT	-14.05M	-47.74M	-149M	-110M	-16.48M
Effective Tax Rate - (Ratio)	-4.03	-2.73	-0	-	-0.28
Total Current Taxes	871K	-1K	-	-	107K
Total Deferred Taxes	123K	1.75M	4K	-	-
Normalized Net Income	-15.25M	-39.19M	-109M	-83.7M	-25.4M

Fiscal Period: December	2021 (CZK)	2022 (CZK)	2023 (CZK)	2024 (CZK)	2025 (CZK)
Assets
Cash And Equivalents	71.61M	20.67M	10.85M	10.17M	15.64M
Total Cash And Short Term Investments	71.61M	20.67M	10.85M	10.17M	15.64M
Accounts Receivable, Total	156M	142M	130M	67.45M	39.33M
Other Receivables	28.38M	55.1M	38.7M	11.09M	23.46M
Total Receivables	185M	197M	169M	78.54M	62.79M
Inventory	155M	187M	96.17M	54.74M	63.38M
Prepaid Expenses	-	-	-	-	1.91M
Other Current Assets, Total	-	-	4.17M	2.72M	-
Total Current Assets	412M	405M	280M	146M	144M
Gross Property Plant And Equipment	81.51M	107M	105M	71.5M	47.29M
Accumulated Depreciation	-19.08M	-32.49M	-47.76M	-50.36M	-38.28M
Net Property Plant And Equipment	62.43M	74.36M	57.63M	21.14M	9M
Long-term Investments	4.05M	9.18M	-	-	-
Goodwill	26.9M	23.78M	21.32M	19.02M	16.73M
Other Intangibles, Total	81.81M	89.6M	67.33M	39M	22.71M
Loans Receivable Long-Term	-	-	5.12M	5.13M	-
Other Long-Term Assets, Total	2.38M	3.78M	8.39M	6.88M	4.98M
Total Assets	589M	606M	440M	237M	197M
Liabilities
Accounts Payable, Total	-	-	279M	162M	149M
Accrued Expenses, Total	15.89M	8.47M	17.06M	94.17M	5.32M
Short-term Borrowings	-	-	52.1M	44.85M	52.9M
Current Portion of Long-Term Debt	-	-	21.22M	1.2M	1.2M
Current Income Taxes Payable	-	-	11.34M	7.73M	1.67M
Other Current Liabilities	348M	434M	15.09M	17.32M	120M
Total Current Liabilities	364M	442M	396M	327M	330M
Long-Term Debt	-	-	3.68M	2.4M	1.2M
Other Non Current Liabilities	21.45M	24.93M	9.1M	4.73M	3.81M
Total Liabilities	385M	467M	409M	334M	335M
Common Stock, Total	2.5M	2.52M	2.71M	2.71M	2.71M
Additional Paid In Capital	390M	389M	279M	279M	279M
Retained Earnings	-188M	-251M	-426M	-553M	-592M
Comprehensive Income and Other	-	-	177M	177M	177M
Total Common Equity	204M	140M	32.85M	-93.98M	-134M
Minority Interest	-275K	-1.21M	-2.14M	-2.77M	-4.06M
Total Equity	204M	139M	30.71M	-96.75M	-138M
Total Liabilities And Equity	589M	606M	440M	237M	197M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	-	2.52M	2.71M	2.71M	2.71M
ECS Total Common Shares Outstanding	-	2.52M	2.71M	2.71M	2.71M
Book Value / Share	-	55.59	12.14	-34.72	-49.45
Tangible Book Value	95.67M	26.76M	-55.8M	-152M	-173M
Tangible Book Value Per Share	-	10.61	-20.62	-56.16	-64.02
Total Debt	0	0	77M	48.45M	55.3M
Net Debt	-71.61M	-20.67M	66.16M	38.28M	39.66M
Minority Interest, Total (Incl. Fin. Div)	-275K	-1.21M	-2.14M	-2.77M	-4.06M
Account Code - Inventory Valuation	-	5	5	5	5
Inventories - Raw Materials, Total	-	-	126K	-	-
Inventories - Finished Goods, Total	155M	187M	96.05M	54.74M	63.38M
Buildings, Total	2.9M	2.88M	1.06M	1.07M	315K
Machinery, Total	60.53M	87.59M	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	114K	23K	-	-	-

Fiscal Period: December	2021 (CZK)	2022 (CZK)	2023 (CZK)	2024 (CZK)	2025 (CZK)
Net Income	-25.5M	-64.94M	-175M	-126M	-38.87M
Depreciation & Amortization - CF	9.29M	14.67M	20.3M	17.29M	12.61M
Amortization of Goodwill and Intangible Assets - (CF)	13.02M	3.18M	2.53M	2.36M	2.36M
Depreciation & Amortization, Total	22.31M	17.85M	22.83M	19.65M	14.96M
Amortization of Deferred Charges, Total - (CF)	12.64M	35.33M	53.62M	47M	21.68M
(Gain) Loss From Sale Of Asset	52K	95K	19K	3.41M	3.12M
Other Operating Activities, Total	9.01M	-5.52M	16K	5.66M	-9.35M
Change In Accounts Receivable	-28.25M	-14.09M	23.94M	93.26M	17.97M
Change In Inventories	-64.63M	-31.96M	91.04M	39.7M	-7.77M
Change In Accounts Payable	99.03M	25.08M	-50.8M	-128M	-22.17M
Cash from Operations	24.67M	-38.15M	-34.29M	-44.99M	-20.43M
Capital Expenditure	-82.13M	-76.77M	-35.63M	-20.06M	-
Sale of Property, Plant, and Equipment	52K	95K	19K	8.56M	2.8M
Cash from Investing	-82.08M	-76.68M	-35.61M	-11.5M	2.8M
Long-Term Debt Issued, Total	-	4.66M	-	64.15M	16.04M
Total Debt Issued	-	4.66M	-	64.15M	16.04M
Long-Term Debt Repaid, Total	-3.26M	-	-1.1M	-	-
Total Debt Repaid	-3.26M	-	-1.1M	-	-
Issuance of Common Stock	-	21K	67.39M	-	-
Cash from Financing	-3.26M	4.68M	66.29M	64.15M	16.04M
Foreign Exchange Rate Adjustments	499K	452K	445K	-1.08M	-997K
Net Change in Cash	-60.17M	-110M	-3.17M	6.58M	-2.58M
Supplemental Items
Cash Interest Paid	63K	4.76M	10.48M	12.33M	16.98M
Levered Free Cash Flow	-	-22.53M	6.15M	61.26M	18.69M
Unlevered Free Cash Flow	-	-19.55M	12.7M	68.97M	29.3M
Change In Net Working Capital	-	-33.88M	-64.75M	-91.08M	-2.96M
Net Debt Issued / Repaid	-3.26M	4.66M	-1.1M	64.15M	16.04M

Fiscal Period: December	2021 (CZK)	2022 (CZK)	2023 (CZK)	2024 (CZK)	2025 (CZK)
Profitability
Return on Assets	-	-4.99	-17.76	-20.29	-4.74
Return on Total Capital	-	-17.4	-56.04	-231.28	15.74
Return On Equity %	-	-38.34	-207.35	382.73	32.92
Return on Common Equity	-	-37.7	-202.26	411.4	34.12
Margin Analysis
Gross Profit Margin %	0.57	0.01	13.95	14.07	14.9
SG&A Margin	-	-	17.1	17.57	20.62
EBITDA Margin %	0.35	-1.22	-5.9	-6.92	-0.17
EBITA Margin %	-0.04	-1.82	-6.85	-8.25	-1.61
EBIT Margin %	-0.59	-1.95	-6.97	-8.43	-1.88
Income From Continuing Operations Margin %	-1.08	-2.69	-8.25	-9.69	-4.41
Net Income Margin %	-1.07	-2.65	-8.21	-9.64	-4.43
Net Avail. For Common Margin %	-1.07	-2.65	-8.21	-9.64	-4.43
Normalized Net Income Margin	-0.64	-1.6	-5.11	-6.42	-2.9
Levered Free Cash Flow Margin	-	-0.92	0.29	4.7	2.13
Unlevered Free Cash Flow Margin	-	-0.8	0.6	5.29	3.34
Asset Turnover
Asset Turnover	-	4.1	4.08	3.85	4.03
Fixed Assets Turnover	-	35.78	32.31	33.12	58.15
Receivables Turnover (Average Receivables)	-	16.39	15.98	13.21	16.42
Inventory Turnover (Average Inventory)	-	14.29	12.95	14.85	12.63
Short Term Liquidity
Current Ratio	1.13	0.92	0.71	0.45	0.44
Quick Ratio	0.7	0.49	0.45	0.27	0.24
Operating Cash Flow to Current Liabilities	0.07	-0.09	-0.09	-0.14	-0.06
Days Sales Outstanding (Average Receivables)	-	22.27	22.83	27.71	22.24
Days Outstanding Inventory (Average Inventory)	-	25.54	28.19	24.64	28.9
Average Days Payable Outstanding	-	-	64.79	74.79	75.19
Cash Conversion Cycle (Average Days)	-	-	-13.77	-22.44	-24.05
Long Term Solvency
Total Debt/Equity	-	-	250.77	-50.08	-40.1
Total Debt / Total Capital	-	-	71.49	-100.31	-66.95
LT Debt/Equity	-	-	11.97	-2.48	-0.87
Long-Term Debt / Total Capital	-	-	3.41	-4.97	-1.45
Total Liabilities / Total Assets	65.36	77.07	93.02	140.76	169.95
EBIT / Interest Expense	-18.08	-10.02	-14.18	-8.91	-0.97
EBITDA / Interest Expense	10.63	-6.27	-12	-7.32	-0.09
(EBITDA - Capex) / Interest Expense	-95.07	-22.39	-15.4	-8.95	-0.09
Total Debt / EBITDA	-	-	-0.61	-0.54	-36.36
Net Debt / EBITDA	-8.67	0.69	-0.53	-0.42	-26.07
Total Debt / (EBITDA - Capex)	-	-	-0.48	-0.44	-36.36
Net Debt / (EBITDA - Capex)	0.97	0.19	-0.41	-0.35	-26.07
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-	2.81	-12.89	-38.82	-32.8
Gross Profit, 1 Yr. Growth %	-	-97.98	-25.8	-38.3	-28.82
EBITDA, 1 Yr. Growth %	-	-461.74	320.32	-28.21	-98.32
EBITA, 1 Yr. Growth %	-	4.24K	227.57	-26.35	-86.87
EBIT, 1 Yr. Growth %	-	239.76	211.03	-26.01	-85
Earnings From Cont. Operations, 1 Yr. Growth %	-	156.17	167.46	-28.14	-69.44
Net Income, 1 Yr. Growth %	-	154.71	169.4	-28.12	-69.09
Normalized Net Income, 1 Yr. Growth %	-	157.01	177.73	-23.21	-69.66
Diluted EPS Before Extra, 1 Yr. Growth %	-	-	150.92	-28.12	-69.09
Accounts Receivable, 1 Yr. Growth %	-	-8.98	-4.89	-48.13	-41.69
Inventory, 1 Yr. Growth %	-	20.58	-48.63	-43.08	15.78
Net Property, Plant and Equip., 1 Yr. Growth %	-	19.09	-22.5	-63.32	-57.4
Total Assets, 1 Yr. Growth %	-	2.86	-27.44	-46.02	-16.93
Tangible Book Value, 1 Yr. Growth %	-	-72.03	-308.54	172.39	14
Common Equity, 1 Yr. Growth %	-	-31.43	-76.56	-386.11	42.42
Cash From Operations, 1 Yr. Growth %	-	-254.64	-10.12	31.21	-54.6
Capital Expenditures, 1 Yr. Growth %	-	-6.53	-53.59	-43.7	-
Levered Free Cash Flow, 1 Yr. Growth %	-	-	-106.76	895.52	-69.5
Unlevered Free Cash Flow, 1 Yr. Growth %	-	-	-114.44	442.88	-57.52
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-	-	-5.36	-27	-35.88
Gross Profit, 2 Yr. CAGR %	-	-	368.98	-32.34	-33.73
EBITDA, 2 Yr. CAGR %	-	-	290.13	73.71	-89
EBITA, 2 Yr. CAGR %	-	-	1.09K	55.33	-68.9
EBIT, 2 Yr. CAGR %	-	-	225.18	51.7	-66.69
Earnings From Cont. Operations, 2 Yr. CAGR %	-	-	161.75	38.63	-53.14
Net Income, 2 Yr. CAGR %	-	-	161.95	39.15	-52.86
Normalized Net Income, 2 Yr. CAGR %	-	-	167.37	46.04	-51.73
Diluted EPS Before Extra, 2 Yr. CAGR %	-	-	-	34.3	-52.86
Accounts Receivable, 2 Yr. CAGR %	-	-	-8.8	-29.76	-45
Inventory, 2 Yr. CAGR %	-	-	-21.29	-45.93	-18.82
Net Property, Plant and Equip., 2 Yr. CAGR %	-	-	-3.93	-46.68	-60.47
Total Assets, 2 Yr. CAGR %	-	-	-13.61	-37.42	-33.04
Tangible Book Value, 2 Yr. CAGR %	-	-	-23.63	138.33	76.22
Common Equity, 2 Yr. CAGR %	-	-	-59.91	-18.11	101.86
Cash From Operations, 2 Yr. CAGR %	-	-	17.9	8.6	-22.82
Capital Expenditures, 2 Yr. CAGR %	-	-	-34.14	-48.89	-
Levered Free Cash Flow, 2 Yr. CAGR %	-	-	-	-17.94	74.26
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	-	-	-11.47	51.86
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	-	-	-	-18.17	-28.99
Gross Profit, 3 Yr. CAGR %	-	-	-	138.52	-31.18
EBITDA, 3 Yr. CAGR %	-	-	-	121.9	-62.95
EBITA, 3 Yr. CAGR %	-	-	-	371.38	-31.83
EBIT, 3 Yr. CAGR %	-	-	-	98.52	-29.86
Earnings From Cont. Operations, 3 Yr. CAGR %	-	-	-	70.12	-16.26
Net Income, 3 Yr. CAGR %	-	-	-	70.22	-15.72
Normalized Net Income, 3 Yr. CAGR %	-	-	-	76.4	-13.5
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	-	-	-17.7
Accounts Receivable, 3 Yr. CAGR %	-	-	-	-24.44	-33.98
Inventory, 3 Yr. CAGR %	-	-	-	-29.35	-30.31
Net Property, Plant and Equip., 3 Yr. CAGR %	-	-	-	-30.3	-50.52
Total Assets, 3 Yr. CAGR %	-	-	-	-26.14	-31.22
Tangible Book Value, 3 Yr. CAGR %	-	-	-	16.69	86.39
Common Equity, 3 Yr. CAGR %	-	-	-	-22.82	-1.52
Cash From Operations, 3 Yr. CAGR %	-	-	-	22.18	-18.8
Capital Expenditures, 3 Yr. CAGR %	-	-	-	-37.49	-
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-	-41
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	-	-	-30.69